510(k) device
Bone Cement Genta, Bone Cement HV, Bone Cement LV
Tecres S.P.A. · Bone Cement (LOD, Class II) · First FDA decision Jan 9, 2023, newest Jan 9, 2023Hip osteoarthritisKnee osteoarthritis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
1,963
Naming "Bone"
MAUDE reports
0
Brand "Bone", since 2015
PubMed studies
942,100
Mentioning "Bone"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Bone Cement Genta, Bone Cement HV, Bone Cement LV
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Bone (Mineral) Density StudiesNational determinationOn the books150.3Updated Nov 4, 2026
- Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of CancerNational analysisReview closedCAG-00065R2Updated Sep 21, 2026
- Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of CancerNational analysisReview closedCAG-00065RUpdated Sep 21, 2026
- Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of CancerNational determinationOn the books220.6.19Updated Feb 27, 2024
- Bone Mass MeasurementLocal determinationIn effectL39268Palmetto GBAUpdated Jul 16, 2024
- Bone Mass MeasurementLocal determinationIn effectL36460CGS Administrators, LLCUpdated Dec 29, 2023
- Lumbar Artificial Disc Replacement (LADR)National determinationOn the books150.10Updated Nov 4, 2026
- Transcatheter Tricuspid Valve Replacement (TTVR)National analysisReview closedCAG-00467NUpdated Sep 24, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Bone", any status and sponsor, newest update first.
- Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft.Completed
Artoss Inc.Not on our public-company list
NCT04615260 · 29 participants · Start Jul 19, 2021 · Primary completion Dec 31, 2024
Device: NanoBone · For: Degenerative Disc Disease; Spondylolisthesis
Sites: Worcester, Massachusetts
Atılım UniversityAcademic, hospital or other
NCT07949188 · 36 participants · Start Jul 5, 2025 · Primary completion Aug 20, 2025
Device: Kinesio taping; Sham taping · For: Healthy Volunteers (HV)
Sites: Trabzon, Turkey (Türkiye)
- Operator-Assisted Oscilla Audiometry as a Basis for Hearing Aid Fitting (The Oscilla Validation Study)Pivotal-lookingNot yet recruiting
Aalborg University HospitalAcademic, hospital or other
NCT07949643 · 268 participants (planned) · Start Dec 1, 2026 · Primary completion Oct 31, 2027
Device: Oscilla-based hearing aid fitting; Manual audiometry-based hearing aid fitting · For: Hearing Loss, Sensorineural; Presbyacusis
Sites: Aalborg, Denmark; Hobro, Denmark
1,960 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Bone", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LOD
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Bone"[tiab]. The summary above synthesizes these.
- Horizontal bone augmentation by means of guided bone regeneration.
Benic GI, Hämmerle CH · Periodontol 2000 · 2014Research Support, Non-U.S. Gov't, Review
- Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells.
Florencio-Silva R, Sasso GR, Sasso-Cerri E, et al. · Biomed Res Int · 2015Research Support, Non-U.S. Gov't, Review
- The biology of normal bone remodelling.
Katsimbri P · Eur J Cancer Care (Engl) · 2017Review
- Cancer to bone: a fatal attraction.
Weilbaecher KN, Guise TA, McCauley LK · Nat Rev Cancer · 2011Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Roles of osteoclasts in alveolar bone remodeling.
Omi M, Mishina Y · Genesis · 2022Review, Research Support, N.I.H., Extramural
- Biomaterials for bone defect repair: Types, mechanisms and effects.
Wang J, Liu M, Yang C, et al. · Int J Artif Organs · 2024Review
- Bone growth factors.
Mohan S, Baylink DJ · Clin Orthop Relat Res · 1991Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- [Synthetic bone replacement substances].
Busch A, Jäger M · Orthopadie (Heidelb) · 2022English Abstract
- Wolff's Law and bone's structural adaptations to mechanical usage: an overview for clinicians.
Frost HM · Angle Orthod · 1994Review
- Orthobiologics for Bone Healing.
Calcei JG, Rodeo SA · Clin Sports Med · 2019Review
- Osteopetrosis: Gene-based nosology and significance.
Teti A, Whyte MP · Bone · 2023Editorial
Other devices of this type
Also filed under product code LOD.
- Norian Srs Bone CementSynthes (Usa) · PMA 2000
- Cemex System Genta Fast Bone CementExactech, Inc. · 510(k) 2004
- SPECTRUM GV Bone CementOsteoremedies, LLC · 510(k) 2025
- PALACOS R pro, PALACOS R+G pro, PALACOS MV+G proHeraeus Medical GmbH · 510(k) 2021
- Refobacin Bone Cement R (110034355)Biomet France · 510(k) 2026
- Osteopal® VHeraeus Medical GmbH · 510(k) 2024
- Bone Cement-Normal ViscosityBiomecanica Industria E Comerciode Produtos Ortopedicos Ltda · 510(k) 2022
- OGM 1 Polymethylmethacrylate (PMMA) bone cementOrmed Grup Medikal Turizm Saglik Hizmetleri Sanayi VE · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.